Castle Biosciences
CSTL
CSTL
159 hedge funds and large institutions have $549M invested in Castle Biosciences in 2024 Q2 according to their latest regulatory filings, with 32 funds opening new positions, 54 increasing their positions, 50 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
8% more repeat investments, than reductions
Existing positions increased: 54 | Existing positions reduced: 50
0.41% more ownership
Funds ownership: 90.99% → 91.41% (+0.41%)
1% less capital invested
Capital invested by funds: $553M → $549M (-$3.85M)
Holders
159
Holding in Top 10
4
Calls
$12.1M
Puts
$2.83M
Top Buyers
| 1 | +$9.78M | |
| 2 | +$9.06M | |
| 3 | +$3.65M | |
| 4 |
PVI
Pura Vida Investments
New York
|
+$3.34M |
| 5 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
+$2.79M |
Top Sellers
| 1 | -$12.4M | |
| 2 | -$8.74M | |
| 3 | -$4.86M | |
| 4 |
Millennium Management
New York
|
-$4.65M |
| 5 |
BPC
Banque Pictet & Cie
Geneva 73,
Switzerland
|
-$3.7M |